PROVECTUS BIOPHARM COM USD0.001 (PVCT)

0.03
0.00 6.67
OTC
Prev Close 0.03
Open 0.03
Day Low/High 0.03 / 0.03
52 Wk Low/High 0.01 / 0.08
Volume 18.00K
Exchange OTC
Shares Outstanding 370.36B
Market Cap 13.70M
Div & Yield N.A. (N.A)

Latest News

Provectus Biopharmaceuticals Announces Two Poster Presentations On PV-10 For Liver Tumors

Provectus Biopharmaceuticals Announces Two Poster Presentations On PV-10 For Liver Tumors

Provectus Biopharmaceuticals, Inc. (OTCQB:PVCT, www.

(Graphic: Business Wire)

(Graphic: Business Wire)

Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT, www.

Provectus Biopharmaceuticals, Inc. Announces Notification Of NYSE MKT Listing Deficiency

Provectus Biopharmaceuticals, Inc. Announces Notification Of NYSE MKT Listing Deficiency

Provectus Biopharmaceuticals, Inc. (OTCQB:PVCT) ( www.

Provectus Biopharmaceuticals Reports Third Quarter 2016 Financial Results

Provectus Biopharmaceuticals Reports Third Quarter 2016 Financial Results

Provectus Biopharmaceuticals, Inc. (OTCQB:PVCT, www.

Provectus Biopharmaceuticals To Present At Sidoti's Fall 2016 Emerging Growth Conference, November 1, 2016

Provectus Biopharmaceuticals To Present At Sidoti's Fall 2016 Emerging Growth Conference, November 1, 2016

Provectus Biopharmaceuticals, Inc. (OTCQB:PVCT, www.

Trading In Provectus Biopharmaceuticals Common Stock And Warrants Suspended By NYSE MKT

Trading In Provectus Biopharmaceuticals Common Stock And Warrants Suspended By NYSE MKT

Provectus Biopharmaceuticals, Inc. (NYSE MKT:PVCT, www.

Provectus Biopharmaceuticals Files Registration Statement For Rights Offering To Existing Stockholders

Provectus Biopharmaceuticals Files Registration Statement For Rights Offering To Existing Stockholders

Provectus Biopharmaceuticals, Inc. (NYSE MKT: PVCT, www.

Provectus Biopharmaceuticals Announces Acceptance Of Abstract For Poster Presentation At 31st SITC Annual Meeting

Provectus Biopharmaceuticals Announces Acceptance Of Abstract For Poster Presentation At 31st SITC Annual Meeting

Provectus Biopharmaceuticals, Inc. (NYSE MKT: PVCT, www.

Provectus Biopharmaceuticals To Present At Rodman & Renshaw's 18th Annual Global Investment Conference

Provectus Biopharmaceuticals To Present At Rodman & Renshaw's 18th Annual Global Investment Conference

Provectus Biopharmaceuticals, Inc. (NYSE MKT:PVCT, www.

Provectus Biopharmaceuticals, Inc. Announces Closing Of Public Offering

Provectus Biopharmaceuticals, Inc. Announces Closing Of Public Offering

Provectus Biopharmaceuticals, Inc. (NYSE MKT: PVCT) ("Provectus" or the "Company"), a clinical-stage oncology and dermatology biopharmaceutical company, today announced that it has completed its public offering of 240,000...

Provectus Biopharmaceuticals, Inc. Announces Pricing Of Public Offering To Raise $6 Million

Provectus Biopharmaceuticals, Inc. Announces Pricing Of Public Offering To Raise $6 Million

Provectus Biopharmaceuticals, Inc. (NYSE MKT: PVCT, www.

Provectus Biopharmaceuticals, Inc. Announces Proposed Public Offering Of Preferred Stock And Warrants

Provectus Biopharmaceuticals, Inc. Announces Proposed Public Offering Of Preferred Stock And Warrants

Provectus Biopharmaceuticals, Inc. (NYSE MKT:PVCT, www.

Provectus Biopharmaceuticals, Inc. Receives Patent From USPTO Related To Rose Bengal Analogs

Provectus Biopharmaceuticals, Inc. Receives Patent From USPTO Related To Rose Bengal Analogs

Provectus Biopharmaceuticals, Inc. (NYSE MKT:PVCT, www.

Provectus Biopharmaceuticals, Inc. Reports Second Quarter 2016 Financial Results

Provectus Biopharmaceuticals, Inc. Reports Second Quarter 2016 Financial Results

Provectus Biopharmaceuticals, Inc. (NYSE MKT:PVCT, www.

Provectus Biopharmaceuticals Establishes Australian Subsidiary

Provectus Biopharmaceuticals Establishes Australian Subsidiary

Provectus Biopharmaceuticals, Inc. (NYSE MKT:PVCT, www.

Provectus Biopharmaceuticals Announces PV-10 Data Discussed At 6th European Post-Chicago Melanoma/Skin Cancer Meeting

Provectus Biopharmaceuticals Announces PV-10 Data Discussed At 6th European Post-Chicago Melanoma/Skin Cancer Meeting

Provectus Biopharmaceuticals, Inc. (NYSE MKT:PVCT, www.

Provectus Biopharmaceuticals Will Present At 2016 BIO International Convention In San Francisco, CA

Provectus Biopharmaceuticals Will Present At 2016 BIO International Convention In San Francisco, CA

Provectus Biopharmaceuticals, Inc. (NYSE MKT:PVCT, www.

Provectus Biopharmaceuticals Launches Newly Redesigned Website And Official Facebook Page

Provectus Biopharmaceuticals Launches Newly Redesigned Website And Official Facebook Page

Provectus Biopharmaceuticals, Inc. (NYSE MKT:PVCT, www.